Funding for this research was provided by:
National Institute for Health Research
Received: 21 August 2020
Accepted: 24 December 2020
First Online: 12 January 2021
Ethics approval and consent to participate
: The study was approved by the local ethical Committee, Leeds and Bradford with IRAS number 100244. Individuals were enrolled after written informed consent had been obtained.
: No patient identifiable information is included in this manuscript.
: R.A.A received Institutional Research Grants from Abbott, Bayer, Eli Lilly, LifeScan, NovoNordisk, Roche, Takeda as well as honoraria/education support/consultancy from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck Sharp & Dohme, NovoNordisk and Takeda. All other authors declare that they have no competing interests.